Cite

HARVARD Citation

    Hollenberg, R. et al. (2020). Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population. Human vaccines & immunotherapeutics. 16 (6), pp. 1404-1412. [Online]. 
  
Back to record